Schrödinger reported a decrease in total revenue for the third quarter of 2024, while software revenue increased. The company announced a multi-target research and licensing collaboration with Novartis, receiving $150 million upfront. Updated financial guidance for 2024 was provided, with increased confidence in software revenue growth.
Total revenue for the third quarter was $35.3 million, a decrease from $42.6 million in the third quarter of 2023.
Software revenue for the third quarter increased 10% to $31.9 million, compared to $28.9 million in the third quarter of 2023.
Net loss for the third quarter was $38.1 million, compared to a net loss of $62.0 million for the same period in 2023.
Schrödinger updated its 2024 full-year financial guidance, expecting software revenue growth to range from 8% to 13%.
Schrödinger updated its 2024 full-year financial guidance.
Visualization of income flow from segment revenue to net income